Delivery Order SPE2DE24D0013-SPE2D626F682M
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order (XPRSMVP-10) valued at $4,608.40 by the Defense Logistics Agency Medical Supply Chain on December 4, 2025, with an ultimate completion date of December 11, 2025. This delivery order, issued with no set-aside designation, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract is performed at Cepheid's Sunnyvale,...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. As a leading federal supplier of advanced molecular diagnostic systems and reagents, Cepheid has...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $1,680 with an ultimate completion date of November 13, 2025, by the Defense Logistics Agency Medical Supply Chain. This firm fixed-price delivery order, issued without a set-aside designation, represents a continuation of Cepheid's ongoing role as a primary federal supplier of molecular diagnostic solutions. As a manufacturer of advanced diagnostic systems and reagents, Cepheid supplies the federal...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order (XPRSMVP-10) valued at $2,304.20 under a Defense Logistics Agency Medical Supply Chain Indefinite Delivery Contract. This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 19, 2025, involves the supply of molecular diagnostic products, consistent with Cepheid's core business of providing advanced diagnostic solutions. The contract carries no set-aside...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $40,946.80 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, pertains to molecular diagnostic reagents and test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's GeneXpert diagnostic platform. The contract carries no...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $17,162.40 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025. This delivery order, designated XPRSMVP-10, is set to be completed by October 27, 2025, and represents an order for molecular diagnostic reagents and test kits designed for the GeneXpert diagnostic platform. The work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $5,530.08 by the Defense Logistics Agency's Medical Supply Chain on November 24, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents work performed at Cepheid's Sunnyvale, CA facility. As a manufacturer of advanced molecular diagnostic systems and reagents, Cepheid delivers diagnostic...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $13,281.60 by the Defense Logistics Agency Medical Supply Chain on November 20, 2025, with an ultimate completion date of November 28, 2025. The contract, designated as XPRSTREPA-10, is a non-set-aside procurement for diagnostic supplies and reagents. As a leading federal supplier of advanced molecular diagnostic systems, Cepheid specializes in GeneXpert diagnostic platform solutions and...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $27,650.40 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. This firm fixed-price delivery order, designated XPRSMVP-10 with completion targeted for November 20, 2025, represents a procurement of diagnostic testing supplies and reagents under an existing indefinite delivery contract vehicle. The award carries no set-aside designation,...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $2,040 delivery order (Contract No. 4570200483, XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 5, 2025, with an ultimate completion date of December 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is for molecular diagnostic testing supplies and reagents for the GeneXpert diagnostic platform. The award represents a continuation of Cepheid's established...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F682MDelivery Order
Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,482.28 by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, designated as XPRSMVP-10, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract utilizes no set-aside designation, reflecting Cepheid's competitive positioning in the federal molecular diagnostics procurement market. The place of performance is located in Sunnyvale, California, where Cepheid manufactures its diagnostic solutions. Cepheid has established itself as a critical supplier to multiple federal healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard, primarily through supply of its GeneXpert diagnostic platform and associated molecular testing capabilities for infectious diseases including COVID-19, influenza, respiratory syncytial virus, and tuberculosis. The company maintains substantial indefinite delivery contracts with the VA, including a $32.8 million contract with VISN 6 extending through September 2030, which has generated numerous delivery orders supporting clinical laboratory operations across the VA's distributed network of medical centers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 12/1/25 |